Equities

MDRM

US6076741080

Market Closed - OTC Markets Other stock markets 19:30:21 29/05/2024 BST			5-day change	1st Jan Change
0.0059 ^USD	-10.61%		-10.61%	-34.44%

2023	Odern Mobility Aids, Inc. Appoints Dr. Zakiuddin Ahmed, as President	CI
2021	Galileo Life Sciences Inc Continues Development of Its Telehealth Business Model and Announces an Opening Date for Its 'Vcplus Clinics' in October 2021	CI

Modern Mobility Aids, Inc. Appoints Peter J. Rothbart to its Medical Advisory Team

March 28, 2014 at 01:50 pm

Modern Mobility Aids Inc. announced the appointment of Dr. Peter J. Rothbart, M.D., F.R.C.P.C., D.A.B.P.M to the medical advisory team. Dr. Peter J. Rothbart, the former President of Chronic Pain Section of the Ontario Medical Association (OMA): 2000-2010, Chairman of the Chronic Pain Section of the Ontario Medical Association: 1998-2003, and the Past President of the North American Cervicogenic Headache Society brings extensive experience to the company.

Latest news about MODN MOBI

Odern Mobility Aids, Inc. Appoints Dr. Zakiuddin Ahmed, as President	31/10/23	CI
Galileo Life Sciences Inc Continues Development of Its Telehealth Business Model and Announces an Opening Date for Its 'Vcplus Clinics' in October 2021	07/10/21	CI
Galileo Life Sciences, Inc. has Changed its Name to Modern Mobility Aids, Inc	03/10/17	CI
Galileo Life Sciences, Inc. cancelled the acquisition of Novo Healthnet Limited.	08/11/16	CI
Galileo Life Sciences, Inc. agreed to acquire Novo Healthnet Limited.	10/05/16	CI
Modern Mobility Aids, Inc. completed the acquisition of 50% stake in Green Calyx, Inc. from Newland family group of companies.	02/07/15	CI
Modern Mobility Aids, Inc. Announces Executive Changes	20/02/15	CI
Modern Mobility Aids, Inc. Announces Appointment of Dr. Baseer Khan as Chief Medical Director	04/09/14	CI
Modern Mobility Aids, Inc. entered into an agreement to acquire 50% stake in Green Calyx, Inc. from Newland family group of companies.	02/07/14	CI
Modern Mobility Aids, Inc. Announces Resignation of Declan French as Director and Chairman	27/05/14	CI
Modern Mobility Aids Inc. Appoints Ken Pinckard as Chief Executive Officer	03/04/14	CI
Modern Mobility Aids, Inc. Appoints Peter J. Rothbart to its Medical Advisory Team	28/03/14	CI
Modern Mobility Aids, Inc. Appoints Gilbert Sharpe as Executive Advisor	19/03/14	CI
Modern Mobility Aids, Inc. Announces Executive Changes	11/03/14	CI
Modern Mobility Aids, Inc. Appoints Preston Shea as Director and President	26/02/14	CI
Modern Mobility Aids, Inc. Announces Executive Appointments	12/02/14	CI
Modern Mobility Aids, Inc. Announces Executive Changes	09/05/13	CI
Modern Mobility Aids, Inc. Auditor Raises 'Going Concern' Doubt	21/11/12	CI
Modern Mobility Aids, Inc. has Changed its Ticker to MDRME from MDRM	21/11/12	CI
Modern Mobility Aids, Inc. will Change its Ticker to MDRM from MDRME	16/11/12	CI
Modern Mobility Aids, Inc. will Change its Ticker to MDRME from MDRM	18/10/12	CI
Modern Mobility Aids, Inc. (OTCBB: MDRM) cancelled the acquisition of LumiGene Technologies, Inc. from Mark Michalkoff, Roman Hrycyshyn and Danylo Stolarchuk.	04/08/12	CI
Modern Mobility Aids, Inc. Announces Technology Agreement with LumiGene Technologies Inc. to Develop and Commercialize Molecular Diagnostic Products	04/05/12	CI
Modern Mobility Aids, Inc. Announces Executive Changes	09/04/12	CI

Chart MODN MOBI

Duration

Period

More charts

Company Profile

Modern Mobility Aids Inc., formerly Galileo Life Sciences, Inc., is focused on the life sciences and healthcare industry. The Company is focused on acquiring companies within the biopharmaceutical sector, to focus research and development, and to create a manufacturing capacity in the three segments, which include contract research and manufacturing for life sciences companies, drug and device delivery format packaging and strategic development and production alliances. The Company plans to acquire or invest in multiple licensed producers in Canada and the United States. The Company is focused on exploiting the opportunities presented in the medical marijuana arena. The Company's subsidiary is MDRM Group (Canada) Ltd. The Company also focuses on investing in licensed producers in Canada and the United States, as well as suppliers to the industry. The Company has not generated any revenues and had not commenced any revenue generating activities.

Sector

More about the company